bf/NASDAQ:HALO_icon.jpeg

COM:HALOZYME

Halozyme Therapeutics, Inc.

  • Stock

Last Close

58.47

05/11 21:00

Market Cap

6.74B

Beta: -

Volume Today

1.06M

Avg: -

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal an...Show More

peer of

competitor of